Randomised Trial of Pivampicillin Plus Pivmecillinam vs. Pivampicillin in Children and Young Adults with Chronic Obstructive Pulmonary Disease and Infection with Haemophilus lnf luenzae

References

• Foxwell A. R., Kyd J. M., Cripps A. W. Nontypable Haernophilus influenzae: pathogenesis and prevention. Microbiol. Molecular Biol. Rev. 1998; 62: 294–3081. Foxwell A. R., Kyd J. M., Cripps A. W. Nontypable Haernophilus influenzae: pathogenesis and prevention. Microbiol. Molecular Biol. Rev. 1998; 62: 294–308
   PubMed Web of Science ®Google Scholar
• Pressler X, Szaff M., Høiby N. Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis. Acta Paediatr. Scand. 1984; 73: 541–5472. Pressler X, Szaff M., Høiby N. Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis. Acta Paediatr. Scand. 1984; 73: 541–547
   PubMed Web of Science ®Google Scholar
• Bilton D., Pye A., Johnson M. M., Mitchell J. L., Dodd M., Webb A. K., Stockley R. A., Hill S. L. The isolation and characterization of non-typeable Haemophilus influenzae from sputum of adult cystic fibrosis patients. Eur. Respir. J. 1995; 8: 948–9533. Bilton D., Pye A., Johnson M. M., Mitchell J. L., Dodd M., Webb A. K., Stockley R. A., Hill S. L. The isolation and characterization of non-typeable Haemophilus influenzae from sputum of adult cystic fibrosis patients. Eur. Respir. J. 1995; 8: 948–953
   PubMed Web of Science ®Google Scholar
• Campos J., Román F., Georgiou M., García C, Gómez-Lus R., Cantón R., Escobar H., Barquero F. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J. lnfect. Dis. 1996; 174: 1345–13474. Campos J., Román F., Georgiou M., García C, Gómez-Lus R., Cantón R., Escobar H., Barquero F. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J. lnfect. Dis. 1996; 174: 1345–1347
   PubMed Web of Science ®Google Scholar
• Høiby N. Microbiology of cystic fibrosis. Cystic Fibrosis, M. E. Hodson, D. M. Geddes. Chapman & Hall Medical. 1995; 75–985. Høiby N. Microbiology of cystic fibrosis. Cystic Fibrosis, M. E. Hodson, D. M. Geddes. Chapman & Hall Medical. 1995; 75–98
   Google Scholar
• Mearns M. B. Cystic fibrosis: the first 50 years. A review of the clinical problems and their management. Cystic Fibrosis - Current Topics, J. A. Dodge, D. J. H. Brock, J. H. Widdicombe. Wiley. 1993; 217–2506. Mearns M. B. Cystic fibrosis: the first 50 years. A review of the clinical problems and their management. Cystic Fibrosis - Current Topics, J. A. Dodge, D. J. H. Brock, J. H. Widdicombe. Wiley. 1993; 217–250
   Google Scholar
• Möller L. V. M., Regelink A. G., Grasselier H., Van Alphen L., Dankert J. Antimicrobial susceptibility of Haemophilus influenzae in the respiratory tracts of patients with cystic fibrosis. Antirnicrob. Agents Chemother. 1998; 42: 319–3247. Möller L. V. M., Regelink A. G., Grasselier H., Van Alphen L., Dankert J. Antimicrobial susceptibility of Haemophilus influenzae in the respiratory tracts of patients with cystic fibrosis. Antirnicrob. Agents Chemother. 1998; 42: 319–324
   PubMed Web of Science ®Google Scholar
• Pedersen M., Støvring S., Mørkassel E., Koch C., Høiby N. A comparative study of amoxycillin and pivampicillin in persistent Haemophilus influenzae infection of the lower respiratory tract in children with chronic lung disease. Scand. J. Infect. Dis. 1986; 18: 245–2548. Pedersen M., Støvring S., Mørkassel E., Koch C., Høiby N. A comparative study of amoxycillin and pivampicillin in persistent Haemophilus influenzae infection of the lower respiratory tract in children with chronic lung disease. Scand. J. Infect. Dis. 1986; 18: 245–254
   PubMed Web of Science ®Google Scholar
• Pressler T., Pedersen S. S., Christiansen L., Szaff M., Koch C., Høiby N. Sultamicillin - a new antibiotic in treatment of persistent lower respiratory tract infection caused by. Haemophilus influenzae. J. Antirnicrob. Chemother. 1986; 17: 529–5339. Pressler T., Pedersen S. S., Christiansen L., Szaff M., Koch C., Høiby N. Sultamicillin - a new antibiotic in treatment of persistent lower respiratory tract infection caused by. Haemophilus influenzae. J. Antirnicrob. Chemother. 1986; 17: 529–533
   PubMed Web of Science ®Google Scholar
• Frederiksen B., Lanng S., Koch C., Høiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol. 1996; 21: 153–15810. Frederiksen B., Lanng S., Koch C., Høiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol. 1996; 21: 153–158
   PubMed Web of Science ®Google Scholar
• Bukh N. Double-blind comparison of pivmecillinam plus pivampicillin (Waxid®) with pivampicillin alone in chronic bronchitis: a Danish multi-centre study. Pharmatherapeutica 1983; 3: 422–42811. Bukh N. Double-blind comparison of pivmecillinam plus pivampicillin (Waxid®) with pivampicillin alone in chronic bronchitis: a Danish multi-centre study. Pharmatherapeutica 1983; 3: 422–428
   PubMedGoogle Scholar
• Lund F., Roholt K., Tybring L., Godtfredsen W. O. Mecillinam and pivampicillin - new β-lactam antibiotics with high activity against Gram-negative bacilli. Chemotherapy 1976; 5: 159–16512. Lund F., Roholt K., Tybring L., Godtfredsen W. O. Mecillinam and pivampicillin - new β-lactam antibiotics with high activity against Gram-negative bacilli. Chemotherapy 1976; 5: 159–165
   Google Scholar
• Grunberg E., Cleeland R., Beslind G., DeLorenzo W. F. In vivo synergy between 6β-amidinopenicillanic acid derivatives and other antibiotics. Antimocrob. Agents. Chemother. 1976; 9: 589–59413. Grunberg E., Cleeland R., Beslind G., DeLorenzo W. F. In vivo synergy between 6β-amidinopenicillanic acid derivatives and other antibiotics. Antimocrob. Agents. Chemother. 1976; 9: 589–594
   PubMed Web of Science ®Google Scholar
• Spino M. Pharmacokinetics of drugs in cystic fibrosis. Clin. Rev. Allergy 1991; 9: 169–20114. Spino M. Pharmacokinetics of drugs in cystic fibrosis. Clin. Rev. Allergy 1991; 9: 169–201
   PubMedGoogle Scholar
• Touw D. J., Vinks A. A. T. M. M., Mouton J. W., Horrevorts A. M. Pharm-acokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Clin. Pharmacokinet. 1998; 35: 437–45915. Touw D. J., Vinks A. A. T. M. M., Mouton J. W., Horrevorts A. M. Pharm-acokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Clin. Pharmacokinet. 1998; 35: 437–459
   PubMed Web of Science ®Google Scholar
• Weber A., De Groot R., Ramsey B., Williams J. W., Smith A. Probenecid pharmacokinetics in cystic fibrosis. Dev. Pharmacol. Ther. 1991; 16: 7–1216. Weber A., De Groot R., Ramsey B., Williams J. W., Smith A. Probenecid pharmacokinetics in cystic fibrosis. Dev. Pharmacol. Ther. 1991; 16: 7–12
   PubMedGoogle Scholar
• Eliopoulos G. M., Moellering R. C., Jr. Antimicrobial combinations. Antibiotics in Laboratory Medicine, 4th edn, V. Lorian. Williams and Wilkins, Baltimore 1996; 330–39617. Eliopoulos G. M., Moellering R. C., Jr. Antimicrobial combinations. Antibiotics in Laboratory Medicine, 4th edn, V. Lorian. Williams and Wilkins, Baltimore 1996; 330–396
   Google Scholar
• Kilian M. A. Taxonomic study of the genus Haernophilus, with the proposal of new species. J. Gen. Microbiol. 1976; 93: 9–62, (thesis)18. Kilian M. A. Taxonomic study of the genus Haernophilus, with the proposal of new species. J. Gen. Microbiol. 1976; 93: 9–62, (thesis)
   PubMedGoogle Scholar
• Pedersen S. S. Lung infection with aiginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 1992; 100: 1–79, (thesis)19. Pedersen S. S. Lung infection with aiginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 1992; 100: 1–79, (thesis)
   PubMedGoogle Scholar
• Jensen T., Pedersen S. S., Stafanger G., Haiby N., Koch C., Bondesson G. Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with. Haemophilus influenzae. Scand. J. Infect. Dis. 1988; 20: 517–52520. Jensen T., Pedersen S. S., Stafanger G., Haiby N., Koch C., Bondesson G. Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with. Haemophilus influenzae. Scand. J. Infect. Dis. 1988; 20: 517–525
   PubMed Web of Science ®Google Scholar
• Verhoef J. Prevention of infection by Gram-negative microorganisms. Inf Dis. Clin. North. Am. 1991; 5: 835–84521. Verhoef J. Prevention of infection by Gram-negative microorganisms. Inf Dis. Clin. North. Am. 1991; 5: 835–845
   PubMedGoogle Scholar